Kohli Prashant
Chief Executive Officer
Kohli Prashant has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Sep 10, 2026.
On the most recent filing, Kohli Prashant is listed as Chief Executive Officer at Grace Therapeutics, Inc. Inside the rolling window, Kohli Prashant reported 1 open-market purchase totaling $214K in GRCE and no open-market sales.
Companies traded
Other insiders at GRCE
Insider Buying
$214K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Kohli Prashant made?
Kohli Prashant has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Kohli Prashant trade?
Kohli Prashant has filed SEC Form 4 disclosures for 1 company, including GRCE.
When was Kohli Prashant's most recent SEC Form 4 filing?
Kohli Prashant's most recent SEC Form 4 filing on Tracefour is dated Sep 10, 2026.
What is Kohli Prashant's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Kohli Prashant is listed as Chief Executive Officer.
What is Kohli Prashant's total buy and sell value in the current window?
Inside the rolling retention window, Kohli Prashant bought $214K and sold $0 based on SEC Form 4 filings.
What was Kohli Prashant's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 100,000 GRCE shares on 2026-09-09, worth $214K, per SEC Form 4 filings.